PURPOSE: To determine the clinical features of optic disc progression in patients with ocular hypertension and early glaucoma. PATIENTS: A total of 336 eyes of 168 patients with ocular hypertension or early glaucoma. METHODS: Two glaucoma specialists independently graded the baseline and most recent optic disc photographs for optic disc progression. Optic disc progression was defined as: new or increased neuroretinal rim thinning (2 or more clock hours), notching (1 clock hour or less of thinning of the neuroretinal rim), excavation (undermining of the neuroretinal rim or disc margin), and nerve fiber layer defect(s). They also determined the location of these changes. RESULTS: Ninety-two of 336 eyes (27.4%) showed optic disc progression after a median of 6.1 years. Of those with progression, excavation occurred in 89% of eyes; rim thinning occurring in 54%; and notching occurring in 16%. Fifty-six percent (56%) had 2 or more features of progression. The inferotemporal quadrant was the most common location for progression, but more than 1 location of progression occurred in at least 30% of eyes with progression. CONCLUSIONS: Optic disc progression occurred frequently in this cohort of ocular hypertension and early glaucoma patients. When evaluating the optic disc for glaucomatous progression, eye care providers should pay particular attention to increased excavation and neuroretinal rim thinning-especially in the inferotemporal quadrant.
PURPOSE: To determine the clinical features of optic disc progression in patients with ocular hypertension and early glaucoma. PATIENTS: A total of 336 eyes of 168 patients with ocular hypertension or early glaucoma. METHODS: Two glaucoma specialists independently graded the baseline and most recent optic disc photographs for optic disc progression. Optic disc progression was defined as: new or increased neuroretinal rim thinning (2 or more clock hours), notching (1 clock hour or less of thinning of the neuroretinal rim), excavation (undermining of the neuroretinal rim or disc margin), and nerve fiber layer defect(s). They also determined the location of these changes. RESULTS: Ninety-two of 336 eyes (27.4%) showed optic disc progression after a median of 6.1 years. Of those with progression, excavation occurred in 89% of eyes; rim thinning occurring in 54%; and notching occurring in 16%. Fifty-six percent (56%) had 2 or more features of progression. The inferotemporal quadrant was the most common location for progression, but more than 1 location of progression occurred in at least 30% of eyes with progression. CONCLUSIONS: Optic disc progression occurred frequently in this cohort of ocular hypertension and early glaucomapatients. When evaluating the optic disc for glaucomatous progression, eye care providers should pay particular attention to increased excavation and neuroretinal rim thinning-especially in the inferotemporal quadrant.
Authors: Neil O'Leary; David P Crabb; Steven L Mansberger; Brad Fortune; Michael D Twa; Michael J Lloyd; Aachal Kotecha; David F Garway-Heath; George A Cioffi; Chris A Johnson Journal: Arch Ophthalmol Date: 2010-05
Authors: Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Pamela A Sample; Robert N Weinreb Journal: Am J Ophthalmol Date: 2005-06 Impact factor: 5.258
Authors: D S Kamal; A C Viswanathan; D F Garway-Heath; R A Hitchings; D Poinoosawmy; C Bunce Journal: Br J Ophthalmol Date: 1999-03 Impact factor: 4.638
Authors: Seung Woo Hong; Helen Koenigsman; Ruojin Ren; Hongli Yang; Stuart K Gardiner; Juan Reynaud; Robert M Kinast; Steven L Mansberger; Brad Fortune; Shaban Demirel; Claude F Burgoyne Journal: Am J Ophthalmol Date: 2018-05-09 Impact factor: 5.258
Authors: Sarah Amanullah; Joseph Okudolo; Kamran Rahmatnejad; Shuai-Chun Lin; Sheryl S Wizov; Remy S Manzi Muhire; Lisa A Hark; Cindy X Zheng; Tingting Zhan; George L Spaeth Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-09-05 Impact factor: 3.117
Authors: Hongli Yang; Haomin Luo; Christy Hardin; Yaxing Wang; Jin Wook Jeoung; Cindy Albert; Jayme R Vianna; Glen P Sharpe; Juan Reynaud; Shaban Demirel; Steven L Mansberger; Brad Fortune; Marcelo Nicolela; Stuart K Gardiner; Balwantray C Chauhan; Claude F Burgoyne Journal: Am J Ophthalmol Date: 2019-12-30 Impact factor: 5.258
Authors: Ryan Caezar C David; Sasan Moghimi; Eren Ekici; Jiun L Do; Huiyuan Hou; James A Proudfoot; Alireza Kamalipour; Takashi Nishida; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Am J Ophthalmol Date: 2021-04-25 Impact factor: 5.488
Authors: Muhammad Zain Chauhan; Ann-Katrin Valencia; Maria Carmen Piqueras; Mabel Enriquez-Algeciras; Sanjoy K Bhattacharya Journal: Invest Ophthalmol Vis Sci Date: 2019-04-01 Impact factor: 4.799